Differences in Clinical and Molecular Characteristics of Skin and Soft Tissue Methicillin-Resistant Staphylococcus aureus Isolates between Two Hospitals in Northern California
- 1 June 2007
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 45 (6), 1798-1803
- https://doi.org/10.1128/jcm.01747-06
Abstract
Community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) skin and soft tissue infections (SSTI) are associated with SCC mec IV and Panton-Valentine leukocidin (PVL) genes. CO-MRSA epidemiologic studies suggest that genotypic variation exists within one geographic region. We compared MRSA genotypes and demographic and clinical characteristics of patients with CO-MRSA SSTI between two regional medical centers. We also examined factors associated with SCC mec IV and PVL carriage. A total of 279 MRSA SSTI isolates from 2000 to 2002 at San Francisco General Hospital (SFGH) and Stanford University Hospital (SUH) were genotyped by pulsed-field gel electrophoresis and PCR for SCC mec and PVL genes. Medical records were reviewed for clinical characteristics. Ninety-three percent and 69% of MRSA SSTI were caused by CO-MRSA at SFGH and SUH, respectively. Patients with CO-MRSA SSTI at SFGH were more likely to be nonwhite, younger, homeless, and have no previous exposure to health care ( P < 0.01). SFGH CO-MRSA strains were more likely to carry SCC mec type IV and PVL genes (90% and 55%, respectively) than SUH strains (29% and 16%, respectively). In multivariate analyses, nonwhite ethnicity was associated with both SCC mec type IV and PVL carriage (odds ratio [OR] of 2.65 and 95% confidence interval [CI] of 1.19 to 5.95 and OR of 1.94 and 95% CI of 1.03 to 3.65, respectively). ST8:USA300:IV became the dominant clone at SFGH, but not at SUH, by 2002. Despite geographic proximity, CO-MRSA SSTI exhibited differing SCC mec types, PVL carriage, and clonal dynamics. CO-MRSA SSTI at SUH were more likely to represent feral isolates of nosocomial origin. Clinicians should assess for nosocomial and community risk factors, realizing that different populations with CO-MRSA SSTI may require separate antimicrobial strategies.Keywords
This publication has 30 references indexed in Scilit:
- Population Dynamics of Nasal Strains of Methicillin‐ResistantStaphylococcus aureus—and Their Relation to Community‐Associated Disease ActivityThe Journal of Infectious Diseases, 2005
- Community-associated Methicillin-resistantStaphylococcus aureusin Hospital Nursery and Maternity UnitsEmerging Infectious Diseases, 2005
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesNew England Journal of Medicine, 2005
- A Clone of Methicillin-ResistantStaphylococcus aureusamong Professional Football PlayersNew England Journal of Medicine, 2005
- Hospital Transmission of Community-Acquired Methicillin-Resistant Staphylococcus aureus among Postpartum WomenClinical Infectious Diseases, 2003
- Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Infection in California JailsClinical Infectious Diseases, 2003
- Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in childrenThe Pediatric Infectious Disease Journal, 2002
- Population-Based Community Prevalence of Methicillin-Resistant Staphylococcus aureus in the Urban Poor of San FranciscoClinical Infectious Diseases, 2002
- Epidemic Spread of a Single Clone of Methicillin-Resistant Staphylococcus aureus among Injection Drug Users in Zurich, SwitzerlandClinical Infectious Diseases, 2001
- Community‐Acquired Methicillin‐ResistantStaphylococcus aureusin Hospitalized Adults and Children without Known Risk FactorsClinical Infectious Diseases, 1999